293 related articles for article (PubMed ID: 24289537)
1. Activation of microglia induces symptoms of Parkinson's disease in wild-type, but not in IL-1 knockout mice.
Tanaka S; Ishii A; Ohtaki H; Shioda S; Yoshida T; Numazawa S
J Neuroinflammation; 2013 Dec; 10():143. PubMed ID: 24289537
[TBL] [Abstract][Full Text] [Related]
2. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
3. Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.
De Lella Ezcurra AL; Chertoff M; Ferrari C; Graciarena M; Pitossi F
Neurobiol Dis; 2010 Mar; 37(3):630-40. PubMed ID: 19969084
[TBL] [Abstract][Full Text] [Related]
4. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease.
George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P
Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995
[TBL] [Abstract][Full Text] [Related]
5. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration.
Qin L; Wu X; Block ML; Liu Y; Breese GR; Hong JS; Knapp DJ; Crews FT
Glia; 2007 Apr; 55(5):453-62. PubMed ID: 17203472
[TBL] [Abstract][Full Text] [Related]
6. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
8. The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation.
Couch Y; Alvarez-Erviti L; Sibson NR; Wood MJ; Anthony DC
J Neuroinflammation; 2011 Nov; 8():166. PubMed ID: 22122884
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1beta, and expression of caspase-11 in mice.
Arai H; Furuya T; Yasuda T; Miura M; Mizuno Y; Mochizuki H
J Biol Chem; 2004 Dec; 279(49):51647-53. PubMed ID: 15383538
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms.
Fu SP; Wang JF; Xue WJ; Liu HM; Liu BR; Zeng YL; Li SN; Huang BX; Lv QK; Wang W; Liu JX
J Neuroinflammation; 2015 Jan; 12():9. PubMed ID: 25595674
[TBL] [Abstract][Full Text] [Related]
11. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.
Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF
Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327
[TBL] [Abstract][Full Text] [Related]
12. NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration.
Qin L; Liu Y; Hong JS; Crews FT
Glia; 2013 Jun; 61(6):855-68. PubMed ID: 23536230
[TBL] [Abstract][Full Text] [Related]
13. IL-1β/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-Synuclein pathology in the olfactory bulb, substantia nigra and striatum.
Niu H; Wang Q; Zhao W; Liu J; Wang D; Muhammad B; Liu X; Quan N; Zhang H; Zhang F; Wang Y; Li H; Yang R
Brain Pathol; 2020 Nov; 30(6):1102-1118. PubMed ID: 32678959
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation.
Sharma N; Nehru B
Neurochem Int; 2015 Aug; 87():92-105. PubMed ID: 26055970
[TBL] [Abstract][Full Text] [Related]
15. The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system.
Kuter KZ; Śmiałowska M; Ossowska K
Pharmacol Rep; 2022 Feb; 74(1):67-83. PubMed ID: 34762280
[TBL] [Abstract][Full Text] [Related]
16. Involvement of interleukin-1 in lipopolysaccaride-induced microglial activation and learning and memory deficits.
Tanaka S; Kondo H; Kanda K; Ashino T; Nakamachi T; Sekikawa K; Iwakura Y; Shioda S; Numazawa S; Yoshida T
J Neurosci Res; 2011 Apr; 89(4):506-14. PubMed ID: 21290410
[TBL] [Abstract][Full Text] [Related]
17. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.
Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997
[No Abstract] [Full Text] [Related]
18. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of endotoxin tolerance on peripheral lipopolysaccharide-induced neuroinflammation and dopaminergic neuronal injury.
Yao L; Li P; Chen Q; Hu A; Wu Y; Li B
Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):326-337. PubMed ID: 35260024
[TBL] [Abstract][Full Text] [Related]
20. Tollip, an early regulator of the acute inflammatory response in the substantia nigra.
Humbert-Claude M; Duc D; Dwir D; Thieren L; Sandström von Tobel J; Begka C; Legueux F; Velin D; Maillard MH; Do KQ; Monnet-Tschudi F; Tenenbaum L
J Neuroinflammation; 2016 Dec; 13(1):303. PubMed ID: 27927222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
